MedPath

Enhancing the quality of life of patients with inflammatory bowel disease: a multi-center study investigating cognitive behavioral therapy.

Not yet recruiting
Conditions
quality of life, anxiety and depression of patients with inflammatory bowel disease and cognitive behavioral therapy. Dutch: kwaliteit van leven angst en depressie bij patienten met inflammatoire darmziekten en cognitieve gedragstherapie
Registration Number
NL-OMON19981
Lead Sponsor
Schering_Plough
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

1. A diagnosis of Crohn’s disease or ulcerative colitis;

2. Age above 18;

Exclusion Criteria

1. Known psychiatric disorders that may complicate treatment (e.g., psychosis);

2. Current treatment with psychotherapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Inflammatory Bowel Disease Questionnaire (IBD-Q) will be used to assess primary outcome of the intervention. The IBD-Q measures health-related quality of life and consists of 32 items assessing four dimensions; bowel symptoms, systemic symptoms, emotional functioning, and social functioning. In addition to these four subscale scores, a total score can be calculated. <br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath